B-16
Immunopharmaceutical Development Unit
7F
0709
Next-generation digital biomarker for early diagnosis of dementia
Rapid increase in dementia cases is becoming a serious social issue worldwide. Recent literature suggests that early diagnosis and interventions can prevent dementia progression or onset. This highlights the need for more efficient and convenient diagnostic tools to address the worldwide dementia epidemic. We developed a novel screening test for dementia using an eye-tracking technology (eye-tracking-based cognitive assessment, ETCA) and demonstrated its utility in clinical settings. We are going to further improve its performance and expand our project worldwide.
Responsible Departments
Department of Clinical Gene Therapy
Research Partner
Ai-BrainScience Inc.
Project Members
Principal Investigator
Endowed Chair Professor
Department of Clinical Gene Therapy
Endowed Chair Associate Professor
Department of Clinical Gene Therapy